We use analytics to improve your experience. Cookie policy
NasdaqGS · Healthcare · Statistics
Valuation, profitability, balance-sheet health, and risk metrics for ILMN — every field resolved through TECHi's unified provider chain (Yahoo → FMP → Finnhub → Alpha Vantage) and labelled with the winning source.
Market cap
$21.17B
Enterprise value
—
P/E (TTM)
16.40
Forward P/E
—
PEG ratio
—
Lower = cheaper for the growth
Price / sales
—
Price / book
—
EPS (TTM)
$8.50
Valuation read
A trailing P/E in line with the broad market means ILMN is being priced like an average earner. The PEG ratio (—) is the cleaner read here — it tells you how much you're paying per unit of growth.
Gross margin
—
Operating margin
—
Net margin
—
Return on equity
—
Return on assets
—
Debt / equity
—
Current ratio
—
>1 = covers near-term liabilities
Beta (5Y)
0.84
Dividend yield
4.40%
Forward yield
Shares outstanding
151.91M
52w high
$155.53
52w low
$73.86
Frequently asked
Illumina, Inc. (ILMN) has a market capitalization of $21.2 billion, computed from the latest share count and the live ILMN quote price on TECHi.
Each metric on the ILMN Statistics page is resolved through TECHi's unified-fundamentals layer — Yahoo, FMP, Finnhub, Alpha Vantage in priority order — and labelled with the winning provider so you can verify any number.
Live quote-derived stats (52-week range, current ratio, beta) refresh every market session; reported fundamentals (margins, ROE, debt-to-equity) update each time the issuer files a new statement.
